Artificial Pancreas
Total Trials
9
As Lead Sponsor
1
As Collaborator
8
Total Enrollment
2,806
NCT02971228
Feasibility Trial Testing the Bionic Pancreas With ZP4207
Phase: Phase 2
Role: Collaborator
Start: Nov 30, 2016
Completion: Jun 7, 2017
NCT03840278
The Bihormonal iLet Bionic Pancreas Feasibility Study
Phase: Phase 2/3
Start: May 15, 2019
Completion: Jul 3, 2019
NCT04200313
The Insulin-Only Bionic Pancreas Pivotal Trial
Phase: N/A
Start: Mar 31, 2020
Completion: Jan 14, 2022
NCT04227626
Inpatient Closed Loop Glucose Control With the Gen 2 GlucoSTAT
Start: Apr 30, 2021
Completion: Apr 30, 2021
NCT03258853
Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes
Start: Aug 26, 2021
Completion: Jun 29, 2022
NCT05168657
Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
Start: Mar 31, 2022
Completion: May 23, 2023
NCT06891898
The iLet Experience Study
Role: Lead Sponsor
Start: May 1, 2024
Completion: Jun 30, 2027
NCT06449677
Bionic Pancreas in CFRD
Phase: Phase 3
Start: Sep 24, 2024
Completion: Mar 31, 2026
NCT07011147
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Start: Nov 1, 2025
Completion: Apr 1, 2029
Loading map...